Generic drugs can go through a bioequivalence (BE) study to determine if they have the same safety and efficacy of the innovator (brand-name) drugs, the Food and Drug Administration (FDA) said yesterday, as it clarified four common misconceptions about generic drugs.
When a brand-name drug’s patent expires, other companies can start selling generic versions of the drug, FDA Medicinal Product Division deputy head Lin Yi-chu (林意筑) said.
Of the 23,472 FDA-issued drug permit licenses that are currently valid, 17,510 are for generic drugs, or about 74 percent, Lin said.
Photo: CNA
A drug company that applies for a drug permit license for a generic drug with the same active ingredient, dosage form (the physical form in which a drug is administered) and dosage as a brand-name drug, needs to go through a BE study to prove that its safety and efficacy are the same as the brand-name drug, she said.
However, many people have misconceptions about generic drugs, including that they have not undergone clinical trials, their efficacy is only about 80 percent of the brand-name drugs, attending a BE study is a means to earn money, or that anyone can become a BE study participant, FDA Deputy Director-General Wang Der-yuan (王德原) said.
When an oral drug is administered, it is mainly absorbed in the intestines. In a BE study, blood tests are then taken to determine if the same amount of the active ingredient is released into the blood stream at the same rate as the brand-name drug, Lin said.
The mean values of the pharmacokinetic parameters of both medicinal products are compared and the 90 percent confidence intervals (CIs) are calculated. If the CIs are contained between 80 percent and 125 percent, the BE is demonstrated, she said, adding that this is an internationally agreed upon standard.
A BE study is a type of clinical research. The brand-name drug has already been proven safe and effective, so if the generic drug is proven to be bioequivalent to its brand-name counterpart, its safety and efficacy are also proven, Taiwan Association of Institutional Review Boards chairperson Chang Fung-wei (張芳維) said.
Participants of BE studies do not earn money, but the study organizers usually provide transportation, meals and nutrition fees, he said.
After a drug company gets an institutional review board approval for its BE study, it would send an informed consent form to participants. Those participants are required to strictly follow the instructions detailed in the form, including limits on eating certain foods or taking other drugs, Chang said.
The entire study process must also follow the good clinical practice guidelines to ensure the reliability of clinical trial results and the protection of patients, he added.
In addition, BE study participants must be healthy adults, and there are usually eligibility criteria, such as age, gender and body mass index (BMI) range among others, as well as the exclusion of people with chronic or acute illnesses, pregnant or breast-feeding women, and those taking certain prescription drugs, Chang said.
UPGRADE: The Kang Ding-class frigate is replacing its Chaparall missiles with Tien Chien II and Hua Yang VLS, which would provide it with long-range, 360° air defense Taiwan plans to produce 1,200 to 1,376 Hai Chien II missiles (海劍二, Sea Sword II) — also known as TC-2N — to serve as the standard air defense system of the navy’s surface combatant fleet, a source said yesterday. Last week, the Hai Chien II, the naval version of the Tien Kung II missile (天劍二, Sky Sword II), completed a live-fire test in waters off the National Chungshan Institute of Science and Technology’s Jiupeng facility (九鵬) in Pingtung County’s Manjhou Township (滿州). The MIM72 Chaparral and other dated air defense missiles that currently arm Taiwanese ships have inadequate range to combat Chinese
REASONS FOR TRAVEL: An assistant professor said that proposed amendments to penalize drivers if they used drugs overseas would not deter people from traveling People who operate a motor vehicle under the influence of marijuana would have their driver’s license revoked, even if they used the substance while overseas, the Ministry of Transportation and Communications said yesterday, citing proposed amendments to the Road Traffic Management and Penalty Act (道路交通管理處罰條例). The amendments would also authorize the government to revoke the licenses of people determined to have used Category 1 or Category 2 narcotics, even if they were not operating a vehicle while under the influence of drugs, as well as ban them from taking the license test for three years, the ministry said. People aged 18 or
Johanne Liou (劉喬安), a Taiwanese woman who shot to unwanted fame during the Sunflower movement protests in 2014, returned to Taiwan last night after being deported from the US. She is to stand trial in Taiwan for charges involving embezzlement, fraud and drug crimes. The Criminal Investigation Bureau (CIB) said it took her into custody at Taiwan Taoyuan International Airport and would first question her before transferring her to the New Taipei District Prosecutors’ Office. She was arrested upon disembarking a flight from San Francisco that landed shortly before 7pm. Liou absconded to the US in 2019 after jumping bail
Shih Hsin University President Chen Ching-he (陳清河) yesterday issued a public apology for comments made in his commencement speech last week, stating that he has asked the school to suspend his duties and halt his wages for two months as a show of contrition. At the commencement ceremony on May 30, Chen said, “If you don’t manage your time well, or your own emotions, or your health, then I am telling every one of you — put a quick end to ‘you,’ because the world has no need for ‘you.’” The comments have sparked significant controversy online, and Chen through an open
RSS